Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of ...

Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.

The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.

Vadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug ...

This approval adds to Alembic Pharma's growing portfolio, which now includes 216 ANDA approvals from the USFDA, comprising ...

The estimated market value for Lamotrigine Extended-Release Tablets is approximately $163 million for the year ending June ...

Patient advocacy groups are often funded through pharmaceutical companies, but there are currently no regulations governing ...

GSK's ViiV Healthcare has suspended development of a Phase 2-stage HIV antiviral named VH3739937, a GSK spokesperson ...

The following is a summary of “Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually ...